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Uterus is the primary reproductive organ in women, structurally made up of 3 layers. The innermost layer endometrium acts as site of 
implantation, middle layer myometrium, is made up of 
smooth muscle cells and provides mechanical strength, 
whereas the outer most layer perimetrium, covers the 
uterus. Both endometriosis and uterine leiomyomas are 
leading benign pathologies; originating from endometri-
um and myometrium, respectively. Endometriosis is the 
presence of tissue histologically similar to the endome-
trium at ectopic sites. Common symptoms of endome-
triosis are low back pain, dyspareunia, dysmennorhoea 
and menorrhagia.1 Prevalence rate of endometriosis is 
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BACKGROUND: endometriosis and uterine leiomyomas are leading hormone responsive, benign uterine disor-
ders responsible for high morbidity in women of reproductive age group. a polymorphic (caG)n repeat length 
located in exon 1 of the androgen receptor (ar) gene has been proposed as a risk marker for both endometriosis 
and leiomyomas in some ethnic groups. the present study was carried out to assess the frequency of ar (caG)n 
repeat polymorphism as a risk marker for endometriosis and uterine leiomyomas in asian indian women.
METHODS: dna was isolated from peripheral blood samples of 331 subjects, which include 90 endometriosis 
cases, 140 cases of leiomyomas and 101 healthy age- and sex-matched controls. pcr was carried out to amplify 
exon 1 of the ar gene. all the pcr amplicons were analysed initially on 2% agarose gel electrophoresis, fol-
lowed by bidirectional sequencing to calculate the number caG repeats in individuals.
RESULTS: the caG repeat ranges detected in endometriosis cases were 4-33 (mode-19) and in leiomyomas 
cases 5-34 (mode-20), whereas in controls it was 5-34 (mode-22). a distinct variation was observed in the three 
groups at 14, 18, 19, 20 and 22 (caG)n repeats, which were statistically analyzed using chi-square and odds 
ratio tests. 19 caG repeats were found to be higher in endometriosis cases (19.09%) when compared with con-
trols (9.04%), while 20 caG repeats were higher in leiomyomas cases (14.02%) compared to controls (6.14%). 
a statistically significant (p<0.05) association was observed in 19 and 20 caG repeats in endometriosis and 
leiomyomas, respectively.
CONCLUSION: this is the first report from an asian indian population proposing that 19 and 20 caG repeats of 
the ar gene are associated with endometriosis and leiomyoma and can be regarded as high-risk markers.
10-15% and it is known to account for nearly 50% of 
infertility.2 Laparoscopy/laparotomy is inevitable in the 
precise diagnosis of endometriosis. Leiomyomas or fi-
broids are benign outgrowths of uterus and are one of 
the most common female health disorders. They are 
responsible for a great deal of morbidity with a preva-
lence rate of up to 30%. Leiomyomas are classified as 
sub-serosal, sub-mucosal and intramural based on their 
location.3,4 Although leiomyomas are benign and rarely 
transform into malignant leiomyosarcoma, they fre-
quently lead to infertility and menorrhagia.5 Diagnosis 
is based on symptoms and an ultrasound scan.
Hormones, growth factors, environment and genes 
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are likely to play a role in the etiology and pathogenesis 
of these complex disorders.6-8 Several features are com-
mon to both endometriosis and leiomyomas: 1) They are 
regulated by steroid hormones like estrogen progesterone 
and androgens,9,10 2) therapeutic intervention in both the 
cases is based on the administration of GnRH agonists 
and anti-estrogens,10,11 3) altered expression of hormonal 
receptors have been shown in the ectopic endometrium 
and leiomyoma tissue,12,13 4) angiogenesis  is another 
common characteristic of both the pathologies.14-16 
Androgens are sex-hormones with diverse biological 
actions produced by both ovaries and adrenal glands in 
women. These have major physiological significance in 
sexual differentiation, maintenance of skeletal muscles 
and bones.17 Androgens are prohormones to estrogen 
and they also modulate uterine growth.18 Androgens 
exert their effects by first binding to androgen receptor 
(AR), which is a member of the nuclear hormone re-
ceptor super-family.19 The resulting hormone-receptor 
complex then binds directly to DNA and transactivates 
the androgen-responsive genes. 
Gene polymorphisms are allelic variants accounting at 
least for 1% of population and useful in studies of multi-
factorial disorders. Gene polymorphisms involved in ste-
roid hormone biosynthesis, receptor and signaling may 
be useful biomarkers for hormone- responsive patholo-
gies. A (CAG)n repeat length polymorphism located in 
exon1 of AR gene is known to vary among individuals 
and also between ethnic groups. Variations in (CAG)n 
repeat length has been studied in various female patholo-
gies like breast and ovarian carcinoma, polycystic ovarian 
disease, endometrial carcinoma, pre-eclampsia, endome-
triosis and leiomyomas in different populations.20-32
With regard to the identification of risk markers that 
could provide further insight into the etiology of these 
benign pathologies, the present study was undertaken 
to assess (CAG)n repeat length polymorphisms in AR 
gene to establish its association with endometriosis and 
Leiomyomas risk in our population, if any. 
METHODS
Sampling 
The present study recruited 331 women, which includes 
90 endometriosis and 140 leiomyomas cases along with 
101 normal healthy, age and sex matched controls 2ml 
heparinised blood samples were collected from all sub-
jects. All the cases and controls belonged to Hyderabad, a 
cosmopolitan city in South India. The study group com-
prised women belonging to different social categories. 
All endometriosis cases were confirmed by laparoscopy 
‘or’ laparotomy, while the leiomyoma cases were identi-
fied by clinical symptoms followed by ultrasonography 
examination and confirmed by histopathology after 
hysterectomy or myomectomy. Control group included 
normal healthy women with proven fertility who vis-
ited obstetrics and gynecology departments of different 
hospitals for routine checkup. Clinical details including 
medical, menstrual and obstetric history were obtained 
from patients and controls. This study was approved by 
the institutional ethics committee and informed consent 
was obtained from all the subjects. 
DNA isolation and PCR 
Genomic DNA was isolated from all the blood samples 
using salting out method, routinely carried out in our 
laboratory.33 The DNA was stored at -20°C until PCR 
was carried out. A three step PCR with annealing at 60°C 
was carried out in MJ minicycler and BioER thermalcy-
cler with 25µl reaction volume as described by Govindan 
et al,34 using PCR Master mix (Genetix Biotech Asia) 
and specific primers28 (Bioserve Biotechnologies Ltd, 
Hyderabad, India) for exon 1 region of AR gene .The 
sequence is as follows:
AR primers:
 Forward: 5_TGC GCG AAG TGA TCC AGA AC  
 3_  
Table 1. Statistical analysis of the CAG repeats in cases versus 
controls.
Subject No. of heterozygote Range Mode
Endometriosis 18 (20%) 4-33 repeats 19
Leiomyomas 24 (17.14%) 5-34 repeats 20
Controls 13 (12.87%) 5-34 repeats 22
 
Table 2. Studies of Ar (CAG) n polymorphisms with endometriosis and fibroids.
Study Disease Ethnic group Association
Lattuada et al 2004 Endometriosis Italian Caucasian Lack of association
Hsieh et al 2001 Endometriosis Asian Taiwanese 21 repeats associated
Hsieh et al 2004 Uterine leiomyomas Asian Taiwanese
27 repeats 
associated
rosa et al 2008 Uterine leiomyomas Brazillian No association
Present study 2009
Endometriosis 
and uterine 
leiomyomas
Asian Indian 19 and 20 repeats associated
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Reverse: 5_CTT GGG GAG AAC CAT CCT 
CA 3_  
CAG repeat analysis 
The PCR products ranging in length from 153 bp - 
243bp, were analyzed on 2% agarose gel and bidirec-
tional sequencing was done to determine the CAG re-
peat length in subjects, as described by Hsieh et al.28 
Chi-square (χ2) and Odd’s Ratio tests were used to 
compare the repeat variation between the three groups 
and P value >.05 was considered as significant. 
RESULTS 
In the present study, increased frequency of heterozygotes 
was observed in both endometriosis (20%) and fibroid 
cases (17.14%) when compared to controls (12.87%). The 
observed range of CAG repeats in endometriosis was 4-
33 (Mode=19), and it was 5-34 in both leiomyoma cases 
(Mode=20) and controls (Mode=22) (Table 1). AR gene 
CAG repeat length was significantly different in both en-
dometriosis and leiomyoma cases when compared to con-
trol group. When individual repeat lengths were compared 
in the three groups (Figure 1), variations were observed at 
14, 18, 19, 20 and 22 which were statistically analyzed by 
Chi-square (χ2) and Odd’s Ratio tests . A statistically sig-
nificant (OR: 2.3717; 95% CI: 1.016-5.366, χ2, P=<.05) 
difference was observed in the percentage of individuals 
with 19 CAG repeats in endometriosis cases (19.09%) 
when compared with controls (9.04%). While the per-
centage of individuals with 20 CAG repeats were found 
to be higher in leiomyoma cases (14.02%) compared to 
controls (6.14%), which was statistically significant (OR: 
1.12; 95% CI: 1.01-6.02, χ2, P<.05) (Figure 1). 
DISCUSSION
Benign uterine disorders contribute to significant 
amount of morbidity in women, which include patholo-
gies like endometriosis and leiomyomas. Endometriosis 
is the presence of tissue histologically similar to the en-
dometrium at ectopic sites, while leiomyomas are myo-
metrial   outgrowths of the uterus. Differential origin 
and physiological heterogeneity but similarities in the 
development, as well as therapeutic response indicates 
a predominant role of hormones in their etiopatho-
genesis.This has intrigued us to study the AR (CAG)n 
polymorphism in these diseases in Asian Indian popu-
lation. 
Genetic factors are considered to play a major role 
in the susceptibility and development of both these dis-
eases. Polymorphisms in the candidate genes like hor-
monal receptors, growth factors and angiogenic factors 
have been studied in both the pathologies with varying 
outcomes.30,32,35 Studies reveal aberrant hormonal re-
ceptor expression in leiomyoma and endometrial tis-
sues indicating their crucial role in these disorders.8,36 
Gene polymorphisms in progesterone receptor (PR), 
estrogen receptor (ER) and Androgen Receptor (AR) 
have been studied in both these pathologies in different 
ethnic groups.29-32,34,35,37,38
Androgens are pro hormones of estrogen, playing a 
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Figure 1. Distribution of (CAG)n repeats in cases of endometriosis, leiomyomas and controls.
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major role in normal physiology and uterine pathologies 
in women. The AR gene is located at Xq11.2-q12. It 
spans more than 90 kilobases and contains eight exons. 
The AR protein consists of a highly acidic amino-ter-
minal domain, which functions in transactivation and is 
located entirely in exon 1 (1,586 base pairs).39,40 AR gene 
has a polymorphic cytosine, adenine and guanine (CAG) 
micro satellite in exon 1 that codes for variable length of 
glutamine repeats in the N-terminal domain of AR pro-
tein. These repeat lengths are known to be polymorphic 
because of slippage of DNA polymerase on the multiple 
CAG nucleotides in the DNA template resulting in vari-
ability in the final number of CAG repeats copied during 
DNA replication. The length of the triplet (CAG) repeat 
unit is known to affect the AR activity.41,42 
The AR gene (CAG)n polymorphism has been 
studied with a number of benign and malignant condi-
tions including endometriosis and leiomyomas.28,29,31,32 
A Study on Italian women has shown no association of 
(CAG)n repeat variability with endometriosis.29 While, 
21 CAG repeats were found to be significantly asso-
ciated with endometriosis in Asian Taiwanese wom-
en.28 A study assessing the (CAG)n repeats in Asian 
Taiwanese women, reported that women with 27 CAG 
repeats have a high risk of developing uterine leiomyo-
mas (Table 2).31 Contrary to this finding, another study 
conducted in Brazilian women has reported, no asso-
ciation of AR gene (CAG)n repeat polymorphism with 
uterine leiomyomas.32
This is the first study assessing the AR (CAG)n 
repeat polymorphism in Indian women with endome-
triosis or uterine leiomyomas. Statistically significant 
association of 19 and 20 repeats with endometriosis 
and leiomyomas respectively indicate that they can act 
as risk markers for the above said uterine pathologies in 
our population. In the present study 22 CAG repeats 
was found to be higher among controls (10.52%) com-
pared to endometriosis (4.54%) and leiomyoma cases 
(6.09%). Similar to our results, Thangaraj et al have also 
reported 22 CAG repeats to be higher in Indians indi-
cating that 22 is a common repeat of AR in our popula-
tion.43 In vitro studies have shown the AR alleles with 
low CAG repeat number manifested increased tran-
scriptional activity of AR compared with higher CAG 
repeat number.40,42 Androgen pathways are integrated 
with several other pathways regulating metabolic pro-
cesses in the human body and disturbances in the an-
drogen activity may lead to uterine disorders. Therefore, 
it is reasonable to propose that 19 and 20 repeats in the 
transactivation region of AR may alter the functioning 
of the androgen receptor, and confers risk of developing 
these benign pathologies of uterus. However, investi-
gations in different ethnic groups in concordance with 
functional studies are warranted to understand the role 
of AR gene polymorphism in the development of endo-
metriosis and leiomyomas. 
Acknowledgments
We are thankful to Indian Council of Medical Research 
(Ref. No.5/7/26/2002-RHN) and Department 
of Biotechnology (Ref. BT/PR/5516/MED/14 
/646/2004) for financial support. We are grateful to the 
administration and staff of Durgabai Deshmukh Hospital 
(A.M.S), Govt. Maternity Hospitals (Nayapool and 
Sultanbazar, Hyderabad, India) for providing clinical sam-
ples of patients. Thanks are due to Sister. Maria Arland, 
Head Nurse, GMH, Nayapool, Hyderabad for providing 
clinical samples.
original research reportPOLYmOrPHIC (CAG) n rEPEATS
Hematol Oncol Stem Cell Ther 2(1)     First Quarter 2009 hemoncstem.edmgr.com 293
1. Lessey BA. medical management of Endome-
triosis and Infertility. Fertile Steril. 2000; 73: 1089-
1096.
2. Jackson B, Telner DE. managing the misplaced 
- Approach to Endometriosis. Can Fam Physician. 
2006 ; 52 (11)1420-1424.
3. Vollenhoven BJ, Lawrence AS, Healy DL. Uter-
ine fibroids: a clinical review. Br J Obstet Gynae-
col. 1990; 97; 285-298.
4. Solomon LA, Schimp VL, Ali-Fehmi r, Diamond 
mP, munkarah Ar. Clinical update of smooth 
muscle tumors of the uterus. J minim Invasive  Gy-
necol. 2005;12 401-408.
5. Bajekal N, Li TC. Fibroids, infertility and pregnan-
cy wastage. Hum reprod Update. 2000; 6: 614-620.
6. Koninckx Pr, Ide P, Vandenbroucke W. New 
aspects of the pathophysiology of endometriosis 
and associated infertility. J reprod med. 1980 ; 24 
: 257-264.
7. Kennedy S. The genetics of endometriosis. Eur J 
Obstet Gynecol reprod Biol.1999; 82 129-133.
8. Flake GP, Andersen J, Dixon D. Etiology and 
Pathogenesis of Uterine Leiomyomas: A review 
Environmental Health Perspectives. 2003; 111: (8) 
1037-1054.
9. Gurates B, Bulun SE, Endometriosis : The ulti-
mate hormonal disease. Semin reprod med. 2003 
; 21 (2) : 125-34.
10. Walker CL. role of hormonal and reproductive 
factors in the etiology and treatment of uterine leio-
myoma. recent Prog Horm res. 2002; 57: 277-294.
11. Kauppila A, Vierikko P, Isotalo H, et al. Cytosol 
estrogen and progesterone receptor concentra-
tion and 17-hydroxy steroid dehydrogenase activi-
ties in the endometrium and endometriotic tissue: 
effects of hormonal treatment. Acta Obstet Gyne-
col Scand (Suppl). 1984; 123: 45-52.
12. Nowak rA. Fibroids: Pathophysiology and cur-
rent medical treatment. Baillieres Best Pract res 
Clin Obstet Gynaecol. 1999;13:223-238.
13. Prentice A, randall BJ, Weddell A, mcGill A, 
Henry L, Horne CH, Thomas EJ. alOvarian ste-
roid receptor expression in endometriosis and 
in two potential parent epithelia: endometrium 
and peritoneal mesothelium. Hum reprod. 1992 
Oct;7(9):1318-25.
14. matsuzaki S, Canis m, Darcha C, Dechelotte P, 
Pouly JL, Bruhat mA. Angiogenesis in Endometrio-
sis. Gynecologic and obstetric investigation. 1998; 
46 (2):111-115.
15. Girling JE, rogers PA. recent Advances in En-
dometrial Angiogenesis research. Angiogenesis 
in Endometriosis.Gynecologic and Obsteteric in-
vestigation. 2005; 8 (2) : 89-99. 
16. Fleischer r, Weston GC, Vollenhoven BJ, rog-
ers PA. Pathophysiology of fibroid disease: angio-
genesis and regulation of smooth muscle prolif-
eration. Best Pract res Clin Obstet Gynaecol. 2008 
Aug;22(4):603-14. Epub 2008 mar 12. 
17. Sinha-Hikim I, Taylor WE, Gonzalez-Cadavid 
NF, Zheng W, Bhasin S. Androgen in human skel-
etal muscle and cultured muscle satellite cells: 
up-regulation by androgen treatment. J Clin Endo-
crinol metab. 2004; 89: 5245-5255.
18. Sahlin L, Norstedt G, Eriksson H. Androgen 
regulation of Insulin-like growth factor -1 and the 
Estrogen receptor in the rat Uterus and Liver. J 
Steroid Biochem mol Biol. 1994; 51; 57-66. 
19. Tsai mJ, O’malley BW. molecular mechanisms 
of Action of Steroid and Thyroid receptor Super 
Family members. Annu rev Biochem. 1994; 63: 
451-486.
20. Kasami m, Gobbi H, Dupont WD, Simpson JF, 
Page DL, Vnencak-Jones CL. Androgen receptor 
CAG repeat lengths in ductal carcinoma in situ of 
breast, longest in apocrine variety. Breast. 2000 
Feb;9(1):23-7.
21. Santarosa m, Bidoli E, Gallo A, Steffan A, Boioc-
chi m, Viel . Polymorphic CAG repeat length within 
the androgen receptor gene: identification of a 
subgroup of patients with increased risk of ovarian 
cancer. Oncol rep. 2002 may-Jun;9(3):639-44.
22. mifsud A, ramirez S, Yong EL. Ar gene CAG 
trinucleotide repeats in anovulatory infertility and 
polycystic ovaries. J Clin Endocrinol metab 2000; 
85: 3484 -3488.
23. Terry KL, De Vivo I, Titus-Ernstoff L, Shih mC, 
Cramer DW. Androgen receptor cytosine, ad-
enine, guanine repeats, and haplotypes in rela-
tion to ovarian cancer risk. Cancer res. 2005 Jul 
1;65(13):5974-81
24. Hickey T, Chandy A, Norman rJ. The Ar CAG 
repeat polymorphism and X-chromosome inacti-
vation in Australian Caucasian women with infer-
tility related to polycystic ovary syndrome. J Clin 
Endocrinol metab. 2002 ; 87: 161-165. 
25. Yaron m, Levy T, Chetrit A, Levavi H, Sabah G, 
Schneider D, Halperin r, Ben-rafael Z, Friedman 
E. The polymorphic CAG repeat in the androgen 
receptor gene in Jewish Israeli women with endo-
metrial carcinoma. Cancer. 2001 Sep 1;92(5):1190-
4. 
26. rodríguez G, Bilbao C, ramírez r, Falcón O, 
León L, Chirino r, Falcón O Jr, Díaz BP, rivero 
JF, Perucho m, Díaz-Chico BN, Díaz-Chico JC. 
Alleles with short CAG and GGN repeats in the 
androgen receptor gene are associated with be-
nign endometrial cancer Int J Cancer. 2006 mar 
15;118(6):1420-5.
27. Saarela T, Jääskeläinen J, Tenhola S, Vouti-
lainen r, Heinonen S. Preeclampsia and androgen 
receptor gene CAG repeat length: results from 
both children and women. J Assist reprod Genet. 
2005 Aug;22(7-8):269-75. 
28. Hsieh YY, Chang CC, Tsai FJ, Wu JY, Tsai CH, 
Tsai HD. Androgen receptor trinucleotide poly-
morphism in endometriosis. Fertil Steril. 2001 
Aug;76(2):412-3.
29. Lattuada D, Viganò P, Somigliana E, Odorizzi 
mP, Vignali m, Di Blasio Am. Androgen receptor 
gene cytosine, adenine, and guanine trinucleotide 
repeats in patients with endometriosis. J Soc Gy-
necol Investig. 2004 may;11(4):237-40.
30. Hsieh YY, Wang YK, Chang CC, Lin CS. Estrogen 
receptor a-351, Xba I G and -397 Pvu II C related 
genotypes and alleles are associated with higher 
susceptibilities of endometriosis and leiomyoma. 
Human molecular reproduction. 2007;13 (2): 117-
122. 
31. Hsieh YY, Chang CC, Tsai FJ, Lin CC, Yeh LS, 
Peng CT. Androgen receptor trinucleotide poly-
morphism in leiomyoma. J Assist reprod Genet. 
2004 Dec;21(12):453-7. 
32. rosa FE, Canevari rde A, Ambrosio EP, ramos 
Cirilo PD, Pontes A, rainho CA, rogatto Sr. 814-
823. Polymorphisms of CYP17A1, CYP 19, and an-
drogen Brazilian women with uterine leiomyomas. 
Clin Chem Lab med. 2008 ; 46(6):814-23
33. Alluri rV, mohan V, Komandur S, Chawda K, 
Chaudhuri Jr, Hasan Q. mTHFr C677T gene muta-
tion as a risk factor for arterial stroke: a hospital 
based study. Eur J Neurol. 2005 Jan;12(1):40-4.
34. Govindan S, Ahmad SN, Vedicherla B, Kodati V, 
Jahan P, rao KP, Ahuja Yr & Hasan Q. Association 
of Progesterone receptor Gene Polymorphism 
(PrOGINS) with Endometriosis, Uterine Fibroids 
and Breast Cancer Cancer Biomarkers. 2007; 3(2) 
73-78.
35. Gomes mT, Castro rde A, Villanova FE, da Silva 
ID, Baracat EC, de Lima Gr, Girão mJ The proges-
terone receptor gene polymorphism, PrOGINS, 
may be a factor related to the development of 
uterine fibroids. Fertil Steril. 2007 may;87(5):1116-
21. Epub 2007 Jan 16.
36. Bergquist A, Ferno m. Oestrogen and proges-
terone receptors in endometriotic tissue and en-
dometrium: comparison of different cycle phases 
and ages. Hum reprod. 1993; 8: 2211-2217.
37. Sujatha G. role of genetic factors in the angio-
genesis of endometriosis. Ph.D thesis, Osmania 
University; 2008.
38. Ahmad SN,  role of nuclear and 
mitochondrial genes in the aetiology of uterine 
leiomyomata (fibroids). 2008, Ph.D thesis, Osmania 
University; 2008.
39. Gelmann PE 2002 molecular Biology of the Ar. 
J Clin Oncol 20 13 3001-3015.
40. Chamberlain NL, Driver ED, miesfeld rL. The 
length and location of CAG trinucleotide repeats 
in the androgen receptor N-terminal domain affect 
transactivation function. Nucleic Acids res.1994; 
22: 3181-6.
41. rajender S, Singh L, Thangaraj K. Phenotypic 
heterogeneity of mutations in Ar. Asian J An-
drol.2007; 9: (2) 147-179.
42. Kazemi-Esfarjani P, Trifiro mA, Pinsky L. Evi-
dence for a repressive function of the long poly-
glutamine tract in the human androgen receptor: 
possible pathogenetic relevance for the (CAG)n-
expanded neuronopat. Hum mol Genet. 1995 
Apr;4(4):523-7.
43. Thangaraj K, Joshi mB, reddy AG, Gupta NJ, 
Chakravarty B, Singh L. CAG repeat expansion in 
the androgen receptor gene is not associated with 
male infertility in Indian populations. J Androl. 2002 
Nov-Dec;23(6):815-8.
REFERENCES
